A, well, constructed, dividend, portfolio, help, pave, way, greater, financial, flexibility, retirement, help, enjoy, later, style, Many, retirees, rely, dividend, paying, stocks, extra, income, every, stock, offers, substantial, yield, wind, pulling, weight, retirement, portfolio, 
Retirees, strike, balance, among, stocks, offer, big, enough, yields, create, meaningful, stream, income, trade, valuations, protect, principal, investment, business, strengths, allow, navigate, twists, turns, keep, dividends, flowing, For, investors, seeking, big, dependable, dividends, three, stocks, offer, yields, north, 5, backed, sturdy, businesses, power, long, term, performance, 
FCF, FREE, CASH, FLOW, SOURCES, EXXONMOBIL, YAHOO, FINANCE, 
ExxonMobil, NYSE, XOM, top, position, oil, gas, industry, unlikely, disrupted, along, underappreciated, growth, prospects, great, dividend, The, company, returned, whopping, 14, 44, billion, shareholders, dividends, trailing, 12, period, second, AT, T, terms, total, amount, dividends, paid, across, period, 
Exxon, roughly, 98, payout, ratio, might, look, concerning, company, midst, big, spending, push, elevated, expenses, pressured, earnings, It, investing, new, drilling, production, operations, projected, boost, 2025, earnings, roughly, 140, 2017, levels, assuming, oil, price, 60, per, barrel, But, market, tepid, stock, big, investment, increase, production, taking, place, oil, prices, already, relatively, low, 
The, market, hesitance, embrace, production, push, resulted, stock, trading, opportune, valuation, sporting, fantastic, dividend, yield, Even, renewable, energy, technologies, see, significant, advances, expansion, global, population, economy, mean, increased, fossil, fuel, demand, foreseeable, future, retirees, getting, great, dividend, sturdy, business, Exxon, 
SOURCES, AT, T, YAHOO, FINANCE, 
AT, T, NYSE, T, dividend, growth, slow, last, decade, company, already, offers, great, yield, generating, plenty, cash, flow, fund, distribution, The, company, mobile, wireless, business, sturdy, poised, benefit, 5G, tailwinds, Time, Warner, runway, growth, amid, growing, global, demand, entertainment, content, DirecTV, satellite, television, subsidiary, still, generating, substantial, free, cash, flow, even, though, losing, subscribers, due, cord, cutting, 
Acquiring, DirecTV, Time, Warner, left, AT, T, big, debt, load, seems, clear, company, overpaid, former, making, progress, paying, debt, still, investing, business, The, company, track, generate, 28, billion, free, cash, flow, reduce, debt, 166, billion, 146, billion, It, returned, 14, 8, billion, dividends, shareholders, trailing, 12, period, 
The, chances, mobile, internet, service, seeing, reduced, demand, slim, And, AT, T, large, existing, subscriber, base, network, infrastructure, put, position, bridge, subscribers, faster, 5G, network, service, new, subscription, packages, wearables, smart, cars, Internet, Things, IoT, devices, The, company, also, opportunity, provide, 5G, services, enterprises, IoT, applications, cloud, computing, needs, With, strong, dividend, tailwinds, horizon, mobile, wireless, business, AT, T, stands, great, retirement, stock, 
PAYOUT, GROWTH, STREAK, INCLUDES, ABBVIE, S, TIME, AS, PART, OF, ABBOTT, LABORATORIES, SOURCES, ABBVIE, YAHOO, FINANCE, 
AbbVie, NYSE, ABBV, great, yield, looks, ideally, suited, retirement, portfolio, While, S, P, 500, index, climbed, nearly, 29, 2019, AbbVie, stock, dipped, roughly, 4, sell, stemming, declining, sales, Humira, arthritis, drug, Europe, international, markets, The, biopharmaceutical, company, shares, trade, roughly, 8, 5, times, expected, earnings, look, attractively, valued, retirees, seeking, high, yield, stocks, 
Humira, still, world, top, selling, drug, revenue, launch, biosimilars, tamped, sales, outside, U, S, drug, still, protected, thanks, patents, manufacturing, formulation, protections, marquee, product, start, slip, 2023, Increasing, competition, drug, prompted, company, make, 63, billion, bid, acquire, pharmaceutical, company, Allergan, mostly, known, Botox, 
While, market, balked, price, Allergan, acquisition, deal, significantly, boost, AbbVie, cash, flow, put, even, better, position, continue, delivering, substantial, payout, growth, next, decade, beyond, Humira, sales, likely, continue, pressured, competition, company, received, 14, new, product, major, treatment, approvals, last, five, new, treatments, pipeline, strengthen, business, The, company, also, delivering, stellar, payout, growth, last, decade, trend, looks, poised, continue, 
Before, consider, AT, T, Inc, want, hear, 
Investing, legends, Motley, Fool, Co, founders, David, Tom, Gardner, revealed, believe, 10, best, stocks, investors, buy, right, AT, T, Inc, one, 
